Federal supplier · FY 2016–2025

Takeda Pharmaceuticals Australia Pty Ltd

$648.0 million

Lifetime federal contract value awarded across 5 contract notices.

Awarded by financial year

Click any CN ID to verify the contract notice on AusTender.

CN3743080
$434,085,725
National Blood Authority
National Supply arrangement for imported immunoglobulin products
Published 4 Sept 2025
CN4171512
$22,323,958
National Blood Authority
Procurement of Imported Plasma and Recombinant Products (IPRP) – Adynovate
Published 18 July 2025
CN3924657
$30,209,374
National Blood Authority
Imported Plasma and Recombinant Products
Published 3 June 2025
CN3737775
$109,458,800
National Blood Authority
Supply of Advate and Adynovate Imported Plasma and Recombinant Products
Published 5 July 2024
CN3376159
$51,954,058
National Blood Authority
Supply of Imported Plasma & Recombinant Products
Published 27 Apr 2023

CN ID	Agency	Description	Published	Value
CN3743080	National Blood Authority	National Supply arrangement for imported immunoglobulin products	4 Sept 2025	$434,085,725
CN4171512	National Blood Authority	Procurement of Imported Plasma and Recombinant Products (IPRP) – Adynovate	18 July 2025	$22,323,958
CN3924657	National Blood Authority	Imported Plasma and Recombinant Products	3 June 2025	$30,209,374
CN3737775	National Blood Authority	Supply of Advate and Adynovate Imported Plasma and Recombinant Products	5 July 2024	$109,458,800
CN3376159	National Blood Authority	Supply of Imported Plasma & Recombinant Products	27 Apr 2023	$51,954,058

AusTender contract notices via the OCDS API
Department of Finance · 2013 onward · CC-BY 3.0 AU
Each row above can be verified by clicking the CN ID to view the source notice on AusTender. Methodology at /methodology/#contracts.

Refreshed 23 May 2026 · Caveats